Singapore Institute of Advanced Medicine Holdings Ltd. (SGX:9G2)

Singapore flag Singapore · Delayed Price · Currency is SGD
0.0420
0.00 (0.00%)
At close: Feb 27, 2026
-17.65%
Market Cap 51.72M
Revenue (ttm) 15.93M
Net Income (ttm) -26.03M
Shares Out 1.23B
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 708,300
Average Volume 3,150,850
Open 0.0420
Previous Close 0.0420
Day's Range 0.0420 - 0.0420
52-Week Range 0.0260 - 0.0890
Beta 0.14
RSI 26.45
Earnings Date Feb 15, 2026

About SGXC:9G2

Singapore Institute of Advanced Medicine Holdings Ltd., an investment holding company, provides medical diagnostics and treatments, and radiation therapy and medical oncology services in Singapore. The company offers medical diagnostics and treatments, including cancer-related diagnostics and theragnostic treatments, general diagnostics and health screening, and aesthetic services; and radiation therapy and medical oncology services comprise proton beam therapy, photon radiation therapy, and medical oncology services. It provides clinic and ima... [Read more]

Industry Medical Laboratories
Founded 2011
Country Singapore
Stock Exchange Singapore Exchange - Catalist
Ticker Symbol 9G2
Full Company Profile

Financial Performance

In fiscal year 2025, SGXC:9G2's revenue was 15.71 million, a decrease of -5.63% compared to the previous year's 16.65 million. Losses were -27.05 million, -27.75% less than in 2024.

Financial Statements

News

There is no news available yet.